Drugs / CEA-targeted CAR-T
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07250386 | Oct 2025 → Jun 2028 expected | breast cancer, non-small cell lung carcinoma | Second Affiliated Hospital, School of Medicine, Zhejiang University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CEA-targeted CAR-T | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07250386 ↗ |
| Modality | Cell therapy | “CEA-targeted CAR-T cell preparations” NCT07250386 ↗ |
| Route | Intravenous | “Administration method: intravenous infusion.” NCT07250386 ↗ |